Citation Impact
Citing Papers
Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
2008
High dietary salt decreases antioxidant defenses in the liver of fructose-fed insulin-resistant rats
2013
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
2013
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide
2017
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
2015
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Pharmacophore modeling and parallel screening for PPAR ligands
2007
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds
2005
Acute kidney injury
2012 Standout
Environmental and health effects of the herbicide glyphosate
2017 Standout
Nonalcoholic fatty liver disease and aging: Epidemiology to management
2014
Brown and beige fat: development, function and therapeutic potential
2013 Standout
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003
Pharmacological and nutritional agents promoting browning of white adipose tissue
2012
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡
2010
Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins
2019
No effects of atorvastatin (10mg/d or 80mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study
2015
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Comprehensive Molecular Structure of the Eukaryotic Ribosome
2009 StandoutNobel
Curcumin Inhibits Hepatic Protein-Tyrosine Phosphatase 1B and Prevents Hypertriglyceridemia and Hepatic Steatosis in Fructose-Fed Rats
2010
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial
2017
Benefits of lifestyle modification in NAFLD
2007
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
2010
Future Therapeutic Directions in Reverse Cholesterol Transport
2010
Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease
2008
Fructose and Cardiometabolic Health
2015
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Acute kidney injury
2019 Standout
RACK1 has the nerve to act: Structure meets function in the nervous system
2006
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production
2000 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
trans-Activation of PPAR and Induction of PPAR Target Genes by Perfluorooctane-Based Chemicals
2004
Activation of PPARα lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2
2006
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study
2007
Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependent
2004
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
2016
Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway
2013
The hormone resistin links obesity to diabetes
2001 StandoutNature
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
2006
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The Hallmarks of Aging
2013 Standout
Peroxisomes and oxidative stress
2006
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Meta-analysis of gene expression in the mouse liver reveals biomarkers associated with inflammation increased early during aging
2012
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
2009
Adipokines in liver diseases #
2009
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Fructose and metabolic diseases: New findings, new questions
2010
Calprotectin is released from human skeletal muscle tissue during exercise
2008
Nuclear receptors as therapeutic targets in cholestatic liver diseases
2008
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Xenobiotic-Activated Receptors: From Transcription to Drug Metabolism to Disease
2008
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
The Mechanisms of Action of PPARs
2002 Standout
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat
2015
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
2010
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
2017
The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP
2000
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Works of Núria Roglans being referenced
Impairment of hepatic Stat-3 activation and reduction of PPARα activity in fructose-fed rats
2007
Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver
2002
Hepatic Gene Expression Changes in an Experimental Model of Accelerated Senescence: The SAM-P8 Mouse
2008
Atorvastatin Treatment Induced Peroxisome Proliferator-Activated Receptor α Expression and Decreased Plasma Nonesterified Fatty Acids and Liver Triglyceride in Fructose-Fed Rats
2002
Uncoupling Protein-3 mRNA Levels Are Increased in White Adipose Tissue and Skeletal Muscle of Bezafibrate-Treated Rats
1999
Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats
2013
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients
2004
Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats 1 1Abbreviations: ACO, acyl-CoA oxidase; Apo, apolipoprotein; APRT, adenosyl phosphoribosyl transferase; CT, CTP:phosphocholine cytidylyl transferase; HDL, high-density lipoprotein; HMG-CoA Rd, 3-hydroxy-3-methyl-glutaryl coenzyme A reductase; LDL, low-density lipoprotein; PAP, phosphatidate phosphohydrolase; PPARα, peroxisome proliferator-activated receptor; SREBP, sterol regulatory element binding protein; and VLDL, very-low-density lipoprotein.
2001
Atorvastatin reverses age‐related reduction in rat hepatic PPARα and HNF‐4
2005
Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism
2008
Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs
2004
Simple Sugar Intake and Hepatocellular Carcinoma: Epidemiological and Mechanistic Insight
2014
Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells
2001
High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production
2002